Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.
Zafer TandoğduJustin William CollinsTeresita BeestonJennifer L RohnBela KovesAshwin SachdevaPaola Ruiz PuentesAlexander HaeseAlexandre MottrieAnup KumarAnanthakrishnan SivaramanAshutosh K TewariBenjamin ChallacombeBernardo RoccoCamilo GiedelmanChristian WagnerCraig G RogersDeclan G MurphyDmitry PushkarGabriel Ogaya-PiniesJames R PorterKulthe Ramesh SeetharamMarkus GraefenMarcelo A OrvietoMarcio Covas MoschovasOscar SchatloffPeter WiklundRafael CoelhoRair Jose Valero CarrionTheo M de ReijkeThomas E AhleringTravis RogersHenk G van der PoelVipul R PatelWalter ArtibaniFlorian M E WagenlehnerKris MaesKoon H RhaSenthil NathanTruls E Bjerklund JohansenPeter HawkeyJohn KellyPublished in: BJU international (2021)
Reconfiguring management pathways for patients with prostate cancer is recommended if significant delay (>3-6 months) in surgical management is unavoidable. The mapped pathways provide guidance for such patients. The IPC processes proposed provide a framework for providing RP within an environment with low COVID-19 risk during the outbreak or when the disease remains endemic. The broader concepts could be adapted to other indications beyond prostate cancer surgery.